German pharmaceutical giant Bayer on Tuesday reported further losses in the third quarter as it revised its forecast for the financial year. Net losses in the third quarter were €4.18 billion ($4.44 billion), down from €4.57 billion in the same period last year. Loss per share was €4.26, compared to €4.66 in the previous year. Core earnings per share for the third quarter declined to €0.24 from €0.38, while earnings before interest, tax, depreciation and amortization (EBITDA) before special items decreased by 25.8% to €1.25 billion. The latter figure included a negative currency effect of €94 …